Market Tracker

10/24 8:30am ET

ImmunoGen Inc (NASDAQ:IMGN)

9.22
Data as of Oct 23
 +0.22 / +2.44%
Today’s Change
7.70
Today|||52-Week Range
18.19
-37.15%
Year-to-Date

Today’s Trading

Previous close9.00
Today’s open9.12
Day’s range-- - --
Volume1,239,781
Average volume (3 months)1,023,968
Market cap$792.1M
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+14.70%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book10.46

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...+0.49+4.19%
RLYPRelypsa Inc+1.03+5.50%
FMIFoundation Medicine ...+0.72+3.23%
RDUSRadius Health Inc+0.56+2.94%
Data as of 10/23/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts